209 related articles for article (PubMed ID: 27557506)
1. The requirement of SEPT2 and SEPT7 for migration and invasion in human breast cancer via MEK/ERK activation.
Zhang N; Liu L; Fan N; Zhang Q; Wang W; Zheng M; Ma L; Li Y; Shi L
Oncotarget; 2016 Sep; 7(38):61587-61600. PubMed ID: 27557506
[TBL] [Abstract][Full Text] [Related]
2. PTEN sensitizes MDA-MB-468 cells to inhibition of MEK/Erk signaling for the blockade of cell proliferation.
Jang K; Kim M; Seo HS; Shin I
Oncol Rep; 2010 Sep; 24(3):787-93. PubMed ID: 20664988
[TBL] [Abstract][Full Text] [Related]
3. Pharmacologic inhibition of RAF-->MEK-->ERK signaling elicits pancreatic cancer cell cycle arrest through induced expression of p27Kip1.
Gysin S; Lee SH; Dean NM; McMahon M
Cancer Res; 2005 Jun; 65(11):4870-80. PubMed ID: 15930308
[TBL] [Abstract][Full Text] [Related]
4. Repression of Septin9 and Septin2 suppresses tumor growth of human glioblastoma cells.
Xu D; Liu A; Wang X; Chen Y; Shen Y; Tan Z; Qiu M
Cell Death Dis; 2018 May; 9(5):514. PubMed ID: 29724999
[TBL] [Abstract][Full Text] [Related]
5. Extracellular signal-regulated kinase signaling pathway regulates breast cancer cell migration by maintaining slug expression.
Chen H; Zhu G; Li Y; Padia RN; Dong Z; Pan ZK; Liu K; Huang S
Cancer Res; 2009 Dec; 69(24):9228-35. PubMed ID: 19920183
[TBL] [Abstract][Full Text] [Related]
6. Mitogen-activated protein/extracellular signal-regulated kinase kinase (MEK) inhibitors restore anoikis sensitivity in human breast cancer cell lines with a constitutively activated extracellular-regulated kinase (ERK) pathway.
Fukazawa H; Noguchi K; Murakami Y; Uehara Y
Mol Cancer Ther; 2002 Mar; 1(5):303-9. PubMed ID: 12489846
[TBL] [Abstract][Full Text] [Related]
7. Human endothelial and platelet septin SEPT11: cloning of novel variants and characterisation of interaction partners.
Bartsch I; Bläser S; Röseler S; Sandrock K; Busse A; Huber M; Rempp H; Lieber M; Horn J; Brendle C; Zieger B
Thromb Haemost; 2010 Dec; 104(6):1201-10. PubMed ID: 20978712
[TBL] [Abstract][Full Text] [Related]
8. SUMOylation of human septins is critical for septin filament bundling and cytokinesis.
Ribet D; Boscaini S; Cauvin C; Siguier M; Mostowy S; Echard A; Cossart P
J Cell Biol; 2017 Dec; 216(12):4041-4052. PubMed ID: 29051266
[TBL] [Abstract][Full Text] [Related]
9. Inhibition of either phosphatidylinositol 3-kinase/Akt or the mitogen/extracellular-regulated kinase, MEK/ERK, signaling pathways suppress growth of breast cancer cell lines, but MEK/ERK signaling is critical for cell survival.
Ripple MO; Kalmadi S; Eastman A
Breast Cancer Res Treat; 2005 Sep; 93(2):177-88. PubMed ID: 16187238
[TBL] [Abstract][Full Text] [Related]
10. Activation of peroxisome proliferator-activated receptor-γ (PPARγ) inhibits hepatoma cell growth via downregulation of SEPT2 expression.
Cao LQ; Shao ZL; Liang HH; Zhang DW; Yang XW; Jiang XF; Xue P
Cancer Lett; 2015 Apr; 359(1):127-35. PubMed ID: 25592041
[TBL] [Abstract][Full Text] [Related]
11. Genetic deletion of SEPT7 reveals a cell type-specific role of septins in microtubule destabilization for the completion of cytokinesis.
Menon MB; Sawada A; Chaturvedi A; Mishra P; Schuster-Gossler K; Galla M; Schambach A; Gossler A; Förster R; Heuser M; Kotlyarov A; Kinoshita M; Gaestel M
PLoS Genet; 2014 Aug; 10(8):e1004558. PubMed ID: 25122120
[TBL] [Abstract][Full Text] [Related]
12. Synergistic anti-tumor effects of RAD001 with MEK inhibitors in neuroendocrine tumors: a potential mechanism of therapeutic limitation of mTOR inhibitor.
Iida S; Miki Y; Ono K; Akahira J; Nakamura Y; Suzuki T; Sasano H
Mol Cell Endocrinol; 2012 Mar; 350(1):99-106. PubMed ID: 22178087
[TBL] [Abstract][Full Text] [Related]
13. Prolonged extracellular signal-regulated kinase 1/2 activation during fibroblast growth factor 1- or heregulin beta1-induced antiestrogen-resistant growth of breast cancer cells is resistant to mitogen-activated protein/extracellular regulated kinase kinase inhibitors.
Thottassery JV; Sun Y; Westbrook L; Rentz SS; Manuvakhova M; Qu Z; Samuel S; Upshaw R; Cunningham A; Kern FG
Cancer Res; 2004 Jul; 64(13):4637-47. PubMed ID: 15231676
[TBL] [Abstract][Full Text] [Related]
14. In silico docking of forchlorfenuron (FCF) to septins suggests that FCF interferes with GTP binding.
Angelis D; Karasmanis EP; Bai X; Spiliotis ET
PLoS One; 2014; 9(5):e96390. PubMed ID: 24787956
[TBL] [Abstract][Full Text] [Related]
15. Septin oligomerization regulates persistent expression of ErbB2/HER2 in gastric cancer cells.
Marcus EA; Tokhtaeva E; Turdikulova S; Capri J; Whitelegge JP; Scott DR; Sachs G; Berditchevski F; Vagin O
Biochem J; 2016 Jun; 473(12):1703-18. PubMed ID: 27048593
[TBL] [Abstract][Full Text] [Related]
16. MEK/ERK-dependent uPAR expression is required for motility via phosphorylation of P70S6K in human hepatocarcinoma cells.
Bessard A; Frémin C; Ezan F; Coutant A; Baffet G
J Cell Physiol; 2007 Aug; 212(2):526-36. PubMed ID: 17427199
[TBL] [Abstract][Full Text] [Related]
17. Forchlorfenuron disrupts SEPT9_i1 filaments and inhibits HIF-1.
Vardi-Oknin D; Golan M; Mabjeesh NJ
PLoS One; 2013; 8(8):e73179. PubMed ID: 23977378
[TBL] [Abstract][Full Text] [Related]
18. Over-expression of lipocalin 2 promotes cell migration and invasion through activating ERK signaling to increase SLUG expression in prostate cancer.
Ding G; Fang J; Tong S; Qu L; Jiang H; Ding Q; Liu J
Prostate; 2015 Jun; 75(9):957-68. PubMed ID: 25728945
[TBL] [Abstract][Full Text] [Related]
19. NO donor and MEK inhibitor synergistically inhibit proliferation and invasion of cancer cells.
Furuhashi S; Sugita H; Takamori H; Horino K; Nakahara O; Okabe H; Miyake K; Tanaka H; Beppu T; Baba H
Int J Oncol; 2012 Mar; 40(3):807-15. PubMed ID: 22025280
[TBL] [Abstract][Full Text] [Related]
20. Invasion inhibition by a MEK inhibitor correlates with the actin-based cytoskeleton in lung cancer A549 cells.
Niu J; Mo Q; Wang H; Li M; Cui J; Li Z; Li Z
Biochem Biophys Res Commun; 2012 May; 422(1):80-4. PubMed ID: 22560902
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
